Fragment-based Designing for the Generation of Novel Leads Against BACE1

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|15|1|52-64

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.15, Iss.1, 2015-04, pp. : 52-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 16, 2007-08 ,pp. : 1600-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 1, 2016-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based &bgr;-Secretase (BACE1) Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 20, 2014-05 ,pp. : 3373-3379

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-based drug discovery using the SHAPES method

By Lepre Christopher  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 12, 2007-12 ,pp. : 1555-1566

Informa Healthcare

Access to resources Recommend Favorite

Advances in fragment-based drug discovery platforms

By Orita Masaya   Warizaya Masaichi   Amano Yasushi   Ohno Kazuki   Niimi Tatsuya  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 11, 2009-11 ,pp. : 1125-1144

Informa Healthcare

Access to resources Recommend Favorite